CELL ROBOTICS INTERNATIONAL INC
10QSB/A, 1997-08-28
LABORATORY ANALYTICAL INSTRUMENTS
Previous: LEHMAN BROTHERS CAPITAL PARTNERS II L P, NSAR-A, 1997-08-28
Next: GABELLI CONVERTIBLE SECURITIES FUND INC /DE, NSAR-A, 1997-08-28



<PAGE>
                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549

                                FORM 10-QSB/A-1

             [ X ]   QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF
                      THE SECURITIES EXCHANGE ACT OF 1934
                 For the quarterly period ended June 30, 1997

                                      OR

           [  ]   TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE
                                 EXCHANGE ACT
     For the transition period from ________________  to _________________

                       Commission file number 33-26467-D
                                             ----------

                       CELL ROBOTICS INTERNATIONAL, INC.
                       ---------------------------------
       (Exact Name of small business issuer as Specified in its Charter)

          Colorado                                      84-1153295      
- ---------------------------------                 ---------------------
(State or other jurisdiction                      I.R.S. Employer
of incorporation or organization)                 Identification number

   2715 Broadbent Parkway N.E., Albuquerque, New Mexico               87107
  --------------------------------------------------------------------------
   (Address of Principal Offices)                                 (Zip Code)

Registrant's telephone number, including area code:     (505) 343-1131

Check whether the Issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the last 12 months (or for such
shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.

Yes     [ X ]       No     [ ]

As of August 1, 1997, 5,013,414 shares of Common Stock of the Registrant were
outstanding.

Transitional Small Business Disclosure Format (Check one):
Yes     [ ]         No      [ X ]

<PAGE>
<PAGE>
                                  SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

                                   CELL ROBOTICS INTERNATIONAL, INC.



Dated:      August 28, 1997        By:   /s/ Ronald K. Lohrding
          ------------------            --------------------------
                                        Ronald K. Lohrding,
                                        President



Dated:      August 28, 1997        By:   /s/ John Hanlon
          ------------------            --------------------------
                                        Chief Financial Officer



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEETS AND STATEMENTS OF OPERATIONS FOUND ON PAGES 4, 5 AND 6 OF THE COMPANY'S
FORM 10-QSB FOR THE SIX MONTHS ENDED JUNE 30, 1997, AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               JUN-30-1997
<CASH>                                         521,187
<SECURITIES>                                         0
<RECEIVABLES>                                  431,114
<ALLOWANCES>                                     1,841
<INVENTORY>                                    360,475
<CURRENT-ASSETS>                             1,382,099
<PP&E>                                         738,268
<DEPRECIATION>                                 516,691
<TOTAL-ASSETS>                               1,682,975
<CURRENT-LIABILITIES>                          564,686
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        20,054
<OTHER-SE>                                   1,098,235
<TOTAL-LIABILITY-AND-EQUITY>                 1,682,975
<SALES>                                        534,843
<TOTAL-REVENUES>                               534,843
<CGS>                                          357,397
<TOTAL-COSTS>                                  357,397
<OTHER-EXPENSES>                             1,283,413
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 473
<INCOME-PRETAX>                            (1,144,597)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (1,144,597)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,106,440)
<EPS-PRIMARY>                                   (0.22)
<EPS-DILUTED>                                   (0.22)
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission